Drug Deal Disclosure Act

Hozzl · 2026-07-27T21:18:14Z

Explore the details of House Bill 9699 Drug Deal Disclosure Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

7/27/2026, 9:18 PM

Summary of Bill HR 9699

The bill titled "To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers" was introduced in the 119th Congress on July 15, 2026 under the designation H.R. 9699.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 9699

Bill HR 9699 is currently in the status of Bill Introduced since July 15, 2026. Bill HR 9699 was introduced during Congress 119 and was introduced to the House on July 15, 2026. Bill HR 9699's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of July 15, 2026

Bipartisan Support of Bill HR 9699

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 9699

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 9699

To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.